Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Radiology practice sells imaging center to hospital partner while remaining independent
Fayetteville-based Valley Regional Imaging is unloading its facility to Cape Fear Valley Health, a hospital based in the same Sandhills-region community of southeastern North Carolina.
Hospital system’s physician group adds imaging services by acquiring 40-year-old radiology practice
Seton Imaging and its two locations are now part of Trinity Medical WNY, a multispecialty group owned by physicians but controlled by Catholic Health.
Under-reimbursement keeping radiologists from using key imaging modality, docs warn CMS
Radiologists and other physicians recently wrote to Administrator Mehmet Oz, MD, asking for changes related to contrast-enhanced ultrasound.
FDA details new risk with Johnson & Johnson heart pump controllers after patient’s death
This latest alert was put in place after Johnson & Johnson MedTech learned that some of its Automated Impella Controllers were built to the wrong specifications, impacting their ability to function. Affected devices should not be used going forward.
Lowest dose gadolinium-based contrast agent to date inches closer to FDA approval
Gadoquatrane is now set to go through the regulatory review process on its trek to earning full FDA approval.

Follow-up adherence affected by how and when imaging orders are placed

These are factors that healthcare systems can and should control, experts recently suggested in a new JACR paper.

Johnson & Johnson offers nearly $9B to settle talc lawsuits

Johnson & Johnson has offered to pony up $8.9 billion over 25 years to settle all current and future claims that its talc baby powder contained asbestos and caused cancer to some consumers. It is one of the largest consumer liability settlements in history.

Abbott FreeStyle Libre 2 glucose monitor

Abbott warns that device batteries may overheat or catch fire

The company emphasized that the issues are quite rare. No devices are being recalled, and it is not recommended that customers stop using them.

American College of Radiology ‘deeply concerned’ by ruling striking down key ACA provision

Others such as the AMA and the American Lung Association similarly blasted the decision, which could jeopardize coverage for preventative care.

Deductibles discourage patients from receiving recommended imaging, new survey charges

Such behaviors may lead to delays in cancer diagnosis and treatment and adverse outcomes, experts wrote Tuesday in Radiology.

private equity corporatization business consolidation

Expert panel: Radiologists with MBAs weigh in on private equity’s entrée into imaging

Three members of the specialty recently offered advice to leaders navigating this issue in their organization.

Liver specialists among first to be ably aided by ChatGPT

ChatGPT isn’t capable of unilaterally guiding care for patients with cirrhosis or the liver cancer it tends to spawn, hepatocellular carcinoma (HCC). However, the large-language AI tool can competently assist clinicians.

artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google

Too much too soon? Elon Musk, other tech leaders pause AI development to review ethics

Healthcare is one of the biggest areas of opportunity for AI, with more than 500 health AI algorithms cleared by the FDA over the last several years.

Management

Radiology practice sells imaging center to hospital partner while remaining independent

Hospital system’s physician group adds imaging services by acquiring 40-year-old radiology practice

Under-reimbursement keeping radiologists from using key imaging modality, docs warn CMS

FDA details new risk with Johnson & Johnson heart pump controllers after patient’s death

Lowest dose gadolinium-based contrast agent to date inches closer to FDA approval